Welcome to CSNpharm! For Research Use Only!
Home +1-708-781-1677

DPP4

DPP4

Cat. No. Product Name CAS No. Information
CSN19749 ZY15557 1601480-12-9 ZY15557 is a potent competitive and long acting DPP-4 inhibitor showing similar DPP-4 inhibition across different species
CSN12287 Vildagliptin   274901-16-5 Vildagliptin is an inhibitor of DPP-4 with IC50 of 2.3 nM that is used in the treatment of type 2 diabetes mellitus.
CSN21260 Vildagliptin Dihydrate 2133364-01-7 Vildagliptin (LAF237 dihydrateNVP-LAF 237 dihydrate) is a dipeptidyl peptidase 4 (DPP4) inhibitor that delays the degradation of glucagon-like peptide-1 (GLP-1).
CSN16203 Trelagliptin Succinate   1029877-94-8 Trelagliptin succinate is an highly selective inhibitor of dipeptidyl peptidase-4 DPP-4 that is used for the treatment of type 2 diabetes
CSN16209 Trelagliptin 865759-25-7 Trelagliptin is a long acting dipeptidyl peptidase-4 DPP-4 inhibitor that is being developed for the treatment of type 2 diabetes T2D
CSN13813 Teneligliptin 760937-92-6 Teneligliptin is a potent and long-lasting dipeptidyl peptidase-4 inhibitor and competitively inhibits human plasma rat plasma and human recombinant DPP-4 in vitro with IC50 values of approximately 1 nM
CSN17332 Teneligliptin Hydrobromide   906093-29-6 Teneligliptin is a DPP4 inhibitor with IC50 value of 1 nM. It is commonly used as an add on treatment when meformin is not achieving the expected glycemic goals.
CSN13509 Talabostat Mesylate 150080-09-4 Talabostat mesilate is an orally active specific inhibitor of dipeptidyl peptidases with IC50 of 1 nM for DPP4 including tumor-associated fibroblast activation protein
CSN10172 Sitagliptin Phosphate Monohydrate   654671-77-9 Sitagliptin Phosphate Monohydrate is a potent inhibitor of DPP4 with IC50 of 19 nM in Caco-2 cell extracts
CSN12755 Sitagliptin Phosphate   654671-78-0 Sitagliptin phosphate is a potent inhibitor of DPP4 with IC50 of 19 nM in Caco-2 cell extracts
CSN17002 Sitagliptin 486460-32-6 Sitagliptin is a potent inhibitor of DPP4 with IC50 of 19 nM in Caco-2 cell extracts
CSN13800 Saxagliptin Hydrate   945667-22-1 Saxagliptin the monohydrate form of anhydrous saxagliptin is a reversible and selective DPP4 inhibitor with IC50 of 26 nM It is used for the treatment of type 2 diabetes
CSN12346 Saxagliptin 361442-04-8 Saxagliptin is a selective and reversible DPP4 inhibitor with IC50 of 26 nM
CSN21399 Saikogenin A 5092-09-1 Saikogenin A, extracted from a Chinese herbal plant called Tsai-Fu, is a dipeptidyl peptidase-IV (DPP-IV) inhibitor.
CSN20590 Retagliptin Phosphate 1256756-88-3 Retagliptin phosphate is a DPP-4 inhibitor potentially used for the treatment of Type 2 diabetes
CSN20588 Retagliptin 1174122-54-3 Retagliptin is a DPP-4 inhibitor potentially used for the treatment of Type 2 diabetes
CSN20589 Retagliptin HCl 1174038-86-8 Retagliptin hydrochloride is a DPP-4 inhibitor potentially used for the treatment of Type 2 diabetes
CSN13845 Omarigliptin   1226781-44-7 Omarigliptin also called MA-3102 is an selective inhibitor of DPP-4 with IC50 of 16 nM and Ki of 08 nM Its selectivity is higher than other 168 proteasomes
CSN12323 Linagliptin   668270-12-0 Linagliptin a purine and quinazoline derivative can inhibit DPP-4 with IC50 of 1 nM It functions as an incretin and is used as a hypoglycemic agents in the treatment of type 2 diabetes mellitus
CSN20386 HBK001 1942922-78-2 HBK001 is a dual DPP4 inhibitor and GPR119 agonist that regulates glycemic control and beta cell function ex and in vivo
CSN20422 Gemigliptin 911637-19-9 Gemigliptin is an oral anti-hyperglycemic agent anti-diabetic drug of the dipeptidyl peptidase-4 DPP-4 inhibitor class of drugs
CSN20545 Evogliptin Tartrate 1222102-51-3 Evogliptin tartrate is a potent and selective DPP4 inhibitor dipeptidyl peptidase 4 inhibitor which improves insulin resistance and delays the onset of diabetes
CSN20543 Evogliptin 1222102-29-5 Evogliptin is a potent and selective DPP4 inhibitor dipeptidyl peptidase 4 inhibitor which improves insulin resistance and delays the onset of diabetes
CSN20544 Evogliptin HCl 1246960-27-9 Evogliptin hydrochloride is a potent and selective DPP4 inhibitor dipeptidyl peptidase 4 inhibitor which improves insulin resistance and delays the onset of diabetes
CSN17532 DBPR108 1186426-66-3 DBPR108 is a potent selective and orally bioavailable dipeptide-derived inhibitor of DPP4 with IC50 of 15 nM showing no inhibition on DDP8 and DPP9
CSN19675 AZD7986 1802148-05-5 AZD7986 is a second generation reversible covalent, potent and selective DPP1 inhibitor potentially for the treatment of chronic obstructive pulmonary disease (COPD) with predicted human PK properties suitable for once daily human dosing.
CSN16158 Anagliptin 739366-20-2 Anagliptin is a potent and selective DPP-4 inhibitorIC50 38 nM and 10 fold less potent for DPP-8 and DPP-9
CSN10251 Alogliptin   850649-61-5 Alogliptin is a dipeptidyl peptidase 4 DPP-4 inhibitor with IC50 of 69 nM that exhibits greater selective than DPP-2 DPP-8 and DPP-9
CSN12318 Alogliptin Benzoate   850649-62-6 Alogliptin benzoate is the benzoate salt form of alogliptin which is a selective inhibitor of DPP-4 with IC50 of 69 nM that exhibits greater selective than DPP-2 DPP-8 and DPP-9
<< PREV 1 NEXT >>